News Uni-Bio Science Group Limited

Equities

690 KYG9198H1406

Delayed Hong Kong S.E. Other stock markets 11:55:10 2024-04-24 pm EDT			5-day change	1st Jan Change
0.077 ^HKD	-4.94%		-14.44%	+6.94%

Mar. 27	Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
Feb. 14	Uni-Bio Science's Profit to Climb in 2023	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 27	CI
Uni-Bio Science's Profit to Climb in 2023	Feb. 14	MT
Uni-Bio Science Group Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended 31 December 2023	Feb. 13	CI
Chinese Regulator NMPA Accepts Uni-Bio's Marketing Application for Eye Drops	Jan. 23	MT
Uni-Bio Science Group Limited Announces the Acceptance of its Marketing Application for Diquafosol Sodium Eye Drops by the China National Medical Products Administration	Jan. 23	CI
China Grants Uni-Bio Science's Injection for Orthopedic Diseases	Jan. 22	MT
Uni-Bio Science Group Limited Announces Approval of Marketing Application of Bogutai (Teriparatide Injection) by the China National Medical Products Administration	Jan. 21	CI
Uni-Bio Science Group Limited commences an Equity Buyback for 636,476,815 shares, representing 10% of its issued share capital, under the authorization approved on May 19, 2023.	Dec. 13	CI
Uni-Bio Science Group Limited Announces the Resignation of Ms. Zhang Yanfen as Executive Director	Nov. 15	CI
Uni-Bio Science's Unit Grants 7.2 Million Yuan Loan to Taili Biomedical Technology	23-09-18	MT
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Uni-Bio Science Group Limited Appoints Zhang Yanfen as an Executive Director	23-08-11	CI
Uni Bio Science : Announces 2022 Annual Results，Record High Turnover of HK$440.3 Million and HK$38.5 Million Profit Achieved Expanding Portfolio with New Drug Innovations and Strategic R&D Partnerships	23-03-27	PU
Uni-Bio Science Group Limited Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-27	CI
Uni-Bio Science Group Limited Provides Financial Guidance for the Year Ended 31 December 2022	23-03-06	CI
Uni-Bio Science Unit Renews Property Lease for Two Years	22-12-23	MT
Uni Bio Science : Interim Report 2022	22-09-11	PU
Uni-Bio Science Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022	22-08-29	CI
Uni-Bio Science Group Limited Announces Marketing Application of Bogutai (Teriparatide Injection) Officially Accepted by the China National Medical Products Administration	22-06-28	CI
Uni Bio Science : opens Hong Kong research centre,Future R&D focus in four major businesses	22-06-13	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Uni-Bio Science Group Limited

Equities

690

KYG9198H1406

Summary

Filters